False-positive results in the randomized controlled trial of mammographic screening from age 40 ("age" trial)

25Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

False-positive recall is a recognized disadvantage of mammographic breast screening, and the rate of such recalls may be higher in younger women, potentially limiting the value of screening below age 50.

Cite

CITATION STYLE

APA

Johns, L. E., & Moss, S. M. (2010). False-positive results in the randomized controlled trial of mammographic screening from age 40 (“age” trial). Cancer Epidemiology Biomarkers and Prevention, 19(11), 2758–2764. https://doi.org/10.1158/1055-9965.EPI-10-0623

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free